Contract Analytical Services

Feb 01, 2009
BioPharm International
What the current lack of venture capital means for the CRO market.
Apr 02, 2008
BioPharm International
The outsourced service provider should be considered an extension of your own laboratory.
Sep 01, 2007
BioPharm International
Meeting service levels is a major challenge for pharmaceutical services providers because the requirements of their client base vary widely.
May 01, 2007
BioPharm International
Venture capital insiders say that the flow of funds into biopharma shouldcontinue, driven by the large amount of money available for investment.
Apr 02, 2007
BioPharm International
A tremendous amount of analytical testing is required to support a biopharmaceutical product from discovery, development, and clinical trials, through manufacturing and marketing. Numerous methods are used to fully characterize large molecules because of their complexity—characterizing them is significantly more difficult than it is for small molecules. Biopharmaceuticals are produced via living systems, i.e., E. coli, yeast, or mammalian cells, which require additional testing matrices.
Apr 01, 2005
BioPharm International
Contract manufacturers must plan for increased analytical resources in development and quality control.
lorem ipsum